Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
January 2013 Volume 31 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January 2013 Volume 31 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite

  • Authors:
    • Daigo Sumi
    • Yuri Shimizu
    • Seiichiro Himeno
  • View Affiliations / Copyright

    Affiliations: Laboratory of Molecular Nutrition and Toxicology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan
  • Pages: 259-264
    |
    Published online on: November 16, 2012
       https://doi.org/10.3892/ijmm.2012.1185
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

This study examined whether S100A8 and S100A9, which comprise a complex called calprotectin, are upregulated by exposure to sodium arsenite [As(III)] in nine lines of human-derived cells. HaCaT skin keratinocyte cells, U937 leukemic monocyte cells, and UROtsa urothelial cells showed increased mRNA levels of S100A8 and S100A9 after a 2-week exposure to As(III). To understand the mechanisms regulating S100A9 upregulation in response to As(III), we tested S100A9 promoter-dependent luciferase activity in HaCaT cells transfected with S100A9 promoter (-1000/+429)-fused luciferase cDNA. The results indicated that exposure to As(III) stimulated S100A9 promoter-dependent luciferase activity. In addition, the transcription NF-E2-related factor 2 (Nrf2) was strongly activated in HaCaT cells exposed to As(III). Since two putative antioxidant response elements were found in the S100A9 promoter (ARE1, 5'-ACAGGCAGGG-3' from -897 to -887; ARE2, 5'-ATCTTCCGGAG-3' from -78 to -67), we constructed deletion mutants of each ARE on S100A9 promoter-fused luciferase cDNA. The results indicated that ARE2 is the responsible element for the activation of S100A9 transcription in response to As(III). This report is the first to demonstrate that As(III) enhanced S100A8 and S100A9 expression in human-derived cells and As(III)-induced S100A9 expression is dependent on Nrf2 activation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Engel RR, Hopenhayn-Rich C, Receveur O and Smith AH: Vascular effects of chronic arsenic exposure: a review. Epidemiol Rev. 16:184–209. 1994.PubMed/NCBI

2 

Tseng WP, Chu HM, How SW, Fong JM, Lin CS and Yeh S: Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J Natl Cancer Inst. 40:453–463. 1968.PubMed/NCBI

3 

Kozul CD, Hampton TH, Davey JC, et al: Chronic exposure to arsenic in the drinking water alters the expression of immune response genes in mouse lung. Environ Health Perspect. 117:1108–1115. 2009. View Article : Google Scholar : PubMed/NCBI

4 

Liao WT, Yu CL, Lan CC, et al: Differential effects of arsenic on cutaneous and systemic immunity: focusing on CD4+ cell apoptosis in patients with arsenic-induced Bowen’s disease. Carcinogenesis. 30:1064–1072. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Banerjee N, Banerjee S, Sen R, et al: Chronic arsenic exposure impairs macrophage functions in the exposed individuals. J Clin Immunol. 29:582–594. 2009. View Article : Google Scholar : PubMed/NCBI

6 

Shimizu Y, Fujishiro H, Matsumoto K, Sumi D, Satoh M and Himeno S: Chronic exposure to arsenite induces S100A8 and S100A9 expression in rat RBL-2H3 mast cells. J Toxicol Sci. 36:135–139. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Ehrchen JM, Sunderkotter C, Foell D, Vogl T and Roth J: The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer. J Leukoc Biol. 86:557–566. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Nacken W, Roth J, Sorg C and Kerkhoff C: S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech. 60:569–580. 2003. View Article : Google Scholar : PubMed/NCBI

9 

Kerkhoff C, Nacken W, Benedyk M, Dagher MC, Sopalla C and Doussiere J: The arachidonic acid-binding protein S100A8/A9 promotes NADPH oxidase activation by interaction with p67phox and Rac-2. FASEB J. 19:467–469. 2005.PubMed/NCBI

10 

Kerkhoff C, Sorg C, Tandon NN and Nacken W: Interaction of S100A8/S100A9-arachidonic acid complexes with the scavenger receptor CD36 may facilitate fatty acid uptake by endothelial cells. Biochemistry. 40:241–248. 2001. View Article : Google Scholar : PubMed/NCBI

11 

Loser K, Vogl T, Voskort M, et al: The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med. 16:713–717. 2010. View Article : Google Scholar : PubMed/NCBI

12 

Itoh K, Tong KI and Yamamoto M: Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles. Free Radic Biol Med. 36:1208–1213. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Aono J, Yanagawa T, Itoh K, et al: Activation of Nrf2 and accumulation of ubiquitinated A170 by arsenic in osteoblasts. Biochem Biophys Res Commun. 305:271–277. 2003. View Article : Google Scholar : PubMed/NCBI

14 

Kumagai Y and Sumi D: Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol. 47:243–262. 2007. View Article : Google Scholar : PubMed/NCBI

15 

Fusenig NE and Boukamp P: Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog. 23:144–158. 1998. View Article : Google Scholar : PubMed/NCBI

16 

Rossi MR, Masters JR, Park S, et al: The immortalized UROtsa cell line as a potential cell culture model of human urothelium. Environ Health Perspect. 109:801–808. 2001. View Article : Google Scholar : PubMed/NCBI

17 

Cheng P, Corzo CA, Luetteke N, et al: Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med. 205:2235–2249. 2008. View Article : Google Scholar : PubMed/NCBI

18 

Eue I, Pietz B, Storck J, Klempt M and Sorg C: Transendothelial migration of 27E10+ human monocytes. Int Immunol. 12:1593–1604. 2000. View Article : Google Scholar : PubMed/NCBI

19 

Kerkhoff C, Hofmann HA, Vormoor J, et al: Binding of two nuclear complexes to a novel regulatory element within the human S100A9 promoter drives the S100A9 gene expression. J Biol Chem. 277:41879–41887. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Melkonyan H, Hofmann HA, Nacken W, Sorg C and Klempt M: The gene encoding the myeloid-related protein 14 (MRP14), a calcium-binding protein expressed in granulocytes and monocytes, contains a potent enhancer element in the first intron. J Biol Chem. 273:27026–27032. 1998. View Article : Google Scholar

21 

Pi J, Qu W, Reece JM, Kumagai Y and Waalkes MP: Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res. 290:234–245. 2003. View Article : Google Scholar : PubMed/NCBI

22 

Wang XJ, Sun Z, Chen W, Li Y, Villeneuve NF and Zhang DD: Activation of Nrf2 by arsenite and monomethylarsonous acid is independent of Keap1-C151: enhanced Keap1-Cul3 interaction. Toxicol Appl Pharmacol. 230:383–389. 2008. View Article : Google Scholar : PubMed/NCBI

23 

Wang XJ, Sun Z, Chen W, Eblin KE, Gandolfi JA and Zhang DD: Nrf2 protects human bladder urothelial cells from arsenite and monomethylarsonous acid toxicity. Toxicol Appl Pharmacol. 225:206–213. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Lin L, Stringfield TM, Shi X and Chen Y: Arsenite induces a cell stress-response gene, RTP801, through reactive oxygen species and transcription factors Elk-1 and CCAAT/enhancer-binding protein. Biochem J. 392:93–102. 2005. View Article : Google Scholar : PubMed/NCBI

25 

Barchowsky A, Dudek EJ, Treadwell MD and Wetterhahn KE: Arsenic induces oxidant stress and NF-kappa B activation in cultured aortic endothelial cells. Free Radic Biol Med. 21:783–790. 1996. View Article : Google Scholar : PubMed/NCBI

26 

Barchowsky A, Roussel RR, Klei LR, et al: Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol Appl Pharmacol. 159:65–75. 1999. View Article : Google Scholar

27 

Xu K, Yen T and Geczy CL: IL-10 upregulates macrophage expression of the S100 protein S100A8. J Immunol. 166:6358–6366. 2001. View Article : Google Scholar : PubMed/NCBI

28 

Kuwayama A, Kuruto R, Horie N, Takeishi K and Nozawa R: Appearance of nuclear factors that interact with genes for myeloid calcium binding proteins (MRP-8 and MRP-14) in differentiated HL-60 cells. Blood. 81:3116–3121. 1993.PubMed/NCBI

29 

Shen SC, Yang LY, Lin HY, Wu CY, Su TH and Chen YC: Reactive oxygen species-dependent HSP90 protein cleavage participates in arsenical As(+3)- and MMA(+3)-induced apoptosis through inhibition of telomerase activity via JNK activation. Toxicol Appl Pharmacol. 229:239–251. 2008.PubMed/NCBI

30 

Smith KR, Klei LR and Barchowsky A: Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am J Physiol Lung Cell Mol Physiol. 280:L442–L449. 2001.PubMed/NCBI

31 

Benedyk M, Sopalla C, Nacken W, et al: HaCaT keratinocytes overexpressing the S100 proteins S100A8 and S100A9 show increased NADPH oxidase and NF-kappaB activities. J Invest Dermatol. 127:2001–2011. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Sumi D, Shimizu Y and Himeno S: Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite. Int J Mol Med 31: 259-264, 2013.
APA
Sumi, D., Shimizu, Y., & Himeno, S. (2013). Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite. International Journal of Molecular Medicine, 31, 259-264. https://doi.org/10.3892/ijmm.2012.1185
MLA
Sumi, D., Shimizu, Y., Himeno, S."Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite". International Journal of Molecular Medicine 31.1 (2013): 259-264.
Chicago
Sumi, D., Shimizu, Y., Himeno, S."Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite". International Journal of Molecular Medicine 31, no. 1 (2013): 259-264. https://doi.org/10.3892/ijmm.2012.1185
Copy and paste a formatted citation
x
Spandidos Publications style
Sumi D, Shimizu Y and Himeno S: Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite. Int J Mol Med 31: 259-264, 2013.
APA
Sumi, D., Shimizu, Y., & Himeno, S. (2013). Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite. International Journal of Molecular Medicine, 31, 259-264. https://doi.org/10.3892/ijmm.2012.1185
MLA
Sumi, D., Shimizu, Y., Himeno, S."Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite". International Journal of Molecular Medicine 31.1 (2013): 259-264.
Chicago
Sumi, D., Shimizu, Y., Himeno, S."Involvement of Nrf2 activation in the upregulation of S100A9 by exposure to inorganic arsenite". International Journal of Molecular Medicine 31, no. 1 (2013): 259-264. https://doi.org/10.3892/ijmm.2012.1185
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team